Knowledge and provision of misoprostol among pharmacy workers in Senegal: a cross sectional study [PDF]
BMC Pregnancy and Childbirth, 2017 Background Making misoprostol widely available for management of postpartum haemorrhage (PPH) and post abortion care (PAC) is essential for reducing maternal mortality.
Kate Reiss +7 more
doaj +4 more sources
Inducing labor after fetal demise: a systematic review and meta-analysis of the efficacy and safety of mifepristone and misoprostol combination versus misoprostol alone [PDF]
BMC Pregnancy and ChildbirthIntroduction Intrauterine fetal demise (IUFD), one of the most tragic outcomes of pregnancy, affects approximately 1% of pregnancies. This systematic review aims to assess the efficacy and safety of mifepristone combined with misoprostol versus ...
Maryam Shami +3 more
doaj +2 more sources
Möbius Syndrome: Misoprostol Use and Speech and Language Characteristics [PDF]
International Archives of Otorhinolaryngology, 2014 Introduction Möbius syndrome (MS; VI and VII palsy) is a rare disease that in Brazil has a great frequency because of the use of misoprostol during pregnancy.
Zelita Caldeira Ferreira Guedes
doaj +3 more sources
Evaluation of Low-dose and High-dose Intravaginal Misoprostol for Induction of Labour: A Randomised, Double-blinded, Single Centre Study [PDF]
Journal of Clinical and Diagnostic Research, 2022 Introduction: Misoprostol is a synthetic prostaglandin E1 analogue widely used for cervical ripening and labour induction. However, optimal dose of misoprostol required to induce labour is still controversial.
Gowthami Mummalaneni +4 more
doaj +1 more source
Potency and acceptability of oral misoprostol compared with vaginal misoprostol prior to first trimester abortion [PDF]
New Indian Journal of OBGYN, 2020 Objectives: Present study was done to assess the effectiveness and acceptability of oral misoprostol compared with vaginal misoprostol for cervical priming before termination of first trimester pregnancy.
Varsha Kotwal
doaj +1 more source
Majalah Obstetri dan Ginekologi, 2023 HIGHLIGHTS • Oral misoprostol is more effective than vaginal misoprostol in cervical ripening as a part of induction of labor. • Oral misoprostol is as safe as vaginal misoprostol. ABSTRACT Objective: To compare Bishop score changes and labor
Maskasoni Maskasoni +1 more
doaj +1 more source
Management of early pregnancy loss with mifepristone and misoprostol: clinical predictors of treatment success from a randomized trial. [PDF]
, 2020 BackgroundEarly pregnancy loss is a common event in the first trimester, occurring in 15%-20% of confirmed pregnancies. A common evidence-based medical regimen for early pregnancy loss uses misoprostol, a prostaglandin E1 analog, with a dosage of 800 μg,
Atrio, Jessica M +6 more
core +1 more source
Comparative Study of Oral and Vaginal Misoprostol for Induction of Labour, Maternal and Foetal Outcome [PDF]
Journal of Clinical and Diagnostic Research, 2013 Background: Misoprostol is a new promising agent for cervical ripening and induction of labour .The ideal dose, route and frequency of administration of misoprostol are still under investigation.
Kambhampati Komala +4 more
doaj +1 more source
Journal of Family Medicine and Primary Care, 2023 Introduction: Misoprostol is widely used in the medical management of missed abortions. However, pretreatment with Mifepristone has shown to be effective but still not recommended to be used in missed abortions.
Nidhi Gupta +4 more
doaj +1 more source
Is Misoprostol Cost-effective in the Prevention of Nonsteroidal Anti-inflammatory Drug—Induced Gastropathy in Patients With Chronic Arthritis? [PDF]
, 1994 Whether misoprostol, a synthetic prostaglandin E1 analogue, should be routinely prescribed along with nonsteriodal anti-inflammatory drugs (NSAIDS) to prevent gastric damage is of great clinical importance and has profound cost implications. No consensus
Johannesson, Magnus +2 more
core +1 more source